MediFind
LoginSign Up
Are we missing a condition or feature you’d like to see? MediFind is always evolving and we’d love your feedback.
MediFind
Condition

Apolipoprotein C2 Deficiency

Condition 101

What are the alternative names for Apolipoprotein C2 Deficiency?

  • Hyperlipoproteinemia, type Ib
  • APOC2 deficiency
Learn More About This Condition

Top Global Doctors

View All Doctors

Latest Research

Latest Advance
Study
  • Condition: Familial Chylomicronemia Syndrome (FCS) or Hypertriglyceridemia
  • Journal: Drug design, development and therapy
  • Treatment Used: Volanesorsen
  • Number of Patients: 0
  • Published —
This article discusses volanesorsen in the treatment of familial chylomicronaemia syndrome (FCS), a rare disorder of lipid metabolism characterized by high levels of triglycerides (TGs).
Latest Advance
Study
  • Condition: Familial Chylomicronemia Syndrome (FCS)
  • Journal: Expert review of cardiovascular therapy
  • Treatment Used: Volanesorsen Treatment
  • Number of Patients: 22
  • Published —
This study evaluated the effectiveness of volanesorsen (triglyceride-reducing drug) treatment in patients with familial chylomicronemia syndrome (disrupts the normal breakdown of fats in the body, causing a large amount of fat to build up in the blood; FCS).
Latest Advance
Study
  • Condition: Children With Type 1 Hyperlipoproteinemia
  • Journal: The Journal of clinical endocrinology and metabolism
  • Treatment Used: Orlistat Therapy
  • Number of Patients: 2
  • Published —
The study researched the effects of orlistat therapy in children with type 1 Hyperlipoproteinemia.
View All Latest Research

Clinical Trials

Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 16
  • Start Date: December 9, 2019
Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency
Clinical Trial
Drug
  • Status: Recruiting
  • Study Type: Drug
  • Participants: 80
  • Start Date: March 8, 2019
A Phase 1 Single and Multiple Dose-Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of ARO-APOC3 in Adult Healthy Volunteers as Well as in Severely Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome
Clinical Trial
Other
  • Status: Active, not recruiting
  • Study Type: Other
  • Participants: 20
  • Start Date: January 21, 2019
Effect of Low-Fat Compared to Low-Carbohydrate Diet on Fasting Lipids and Metabolic Profile in Subjects With Multifactorial Chylomicronemia: A Randomized Crossover Study
Clinical Trial
Drug
  • Status: Active, not recruiting
  • Study Type: Drug
  • Participants: 69
  • Start Date: December 31, 2015
ISIS 304801-CS7 The APPROACH Open Label Study Volanesorsen (ISIS 304801) An Open-Label Study of Volanesorsen Administered Subcutaneously to Patients With Familial Chylomicronemia Syndrome (FCS)
View All Clinical Trials